Claudication is an important cause of impaired exercise capacity, which limits a patient's ability to walk and thus to meet the personal, social and occupational demands of daily life. Given that improvement of the walking impairment is the primary goal of treating claudication, exercise performance and functional status of patients with claudication should be measured before and after any intervention. Assessment of functional status in both the laboratory and community settings is important so that the various treatments can be judged as to relative efficacy. Studies have shown that exercise training programs have a clinically important impact on functional capacity in persons with claudication. A meta-analysis showed that pain-free walking time increased 180% and maximal walking time increased 120% in claudicants who participated in an exercise program. Substantial improvements have been found in walking speeds and distances (65% and 44%, respectively), caloric expenditure (31%) and physical functioning (67%).
HiattWRRegensteinerJGHargartenMEWolfelEEBrassEP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation1990; 81: 602–609.
2.
HiattWRWolfelEEMeierRHRegensteinerJG. Superiority of treadmill walking exercise vs. strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation1994; 90: 1866–74.
3.
HiattWRMarshallJABaxterJDiagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol1990; 43: 597–606.
4.
OrchardTJStrandnessDECavanaughPRAssessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop. Circulation1993; 88: 819–28.
5.
HiattWRNawazDRegensteinerJGHossackKF. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardiopulmon Rehabil1988; 12: 525–32.
6.
PattersonJANaughtonJPietrasRJGunnarRM. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. Am J Cardiol1972; 30: 757–62.
7.
GardnerAWSkinnerJSCantwellBWSmithLK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc1991; 23: 402–408.
8.
RegensteinerJGSteinerJFPanzerRJHiattWR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol1990; 2: 142–52.
9.
RegensteinerJGSteinerJFHiattWR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg1996; 23: 104–15.
10.
SallisJFHaskellWLWoodPDPhysical activity assessment methodology in the five-city project. Am J Epidemiol1985; 121: 91–106.
11.
TarlovARWareJEGreenfieldSNelsonECPerrinEZubkoffM.The medical outcomes study. An application of methods for monitoring the results of medical care. JAMA1989; 262: 925–30.
12.
BrandFNAbbottRDKannelWB. Diabetes, intermittent claudication, and risk of cardiovascular events. Diabetes1989; 38: 504–509.
13.
Coleridge-SmithPDThomasPScurrJHDormandyJA. Causes of venous ulceration: a new hypothesis. Br Med J1988; 296: 1726–27.
14.
DormandyJAHoareEKhattabAHArrowsmithDEDormandyTL. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J1973; 4: 581–83.
15.
KannelWBMcGeeDL. Diabetes and cardiovascular disease. The Framingham Study. JAMA1979; 241: 2035–38.
16.
PomrehnPDuncanBWeissfeldLThe association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The lipids research clinics program prevalence study. Circulation1986; 73(suppl I): I-100–I-107.
17.
KannelWBMcGeeDL. Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc1985; 33: 13–18.
18.
TaylorLMDeFrangRDHarrisEJPorterJM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg1991; 13: 128–36.
19.
CantinBMoorjaniSDagenaisGRLupienPJ. Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (The Quebec Cardiovascular Study). Am J Cardiol1995; 75: 1224–28.
20.
QuickCRGCottonLT. The measured effect of stopping smoking on intermittent claudication. Br J Surg1982; 69(suppl): S24–S26.
21.
LundgrenFDahllofALundholmKScherstenTVolkmannR.Intermittent claudication – surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency. Ann Surg1989; 209: 346–55.
22.
CreasyTSMcMillanPJFletcherEWLCollinJMorrisPJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg1990; 4: 135–40.
23.
DoubiletPAbramsHL. The cost of underutilization. Percutaneous transluminal angioplasty for peripheral vascular disease. N Engl J Med1984; 310: 95–102.
24.
JeansWDDantonRMBairdRNHorrocksM.A comparison of the costs of vascular surgery and balloon dilatation in lower limb ischaemic disease. Br J Radiol1986; 59: 453–56.
25.
TunisSRBassEBSteinbergEP. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med1991; 325: 556–62.
26.
PorterJMCutlerBSLeeBYPentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J1982; 104: 66–72.
27.
DahllofABjomtorpPHolmJScherstenT.Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Effect of physical training. Eur J Clin Invest1974; 4: 9–15.
28.
DahllofAHolmJScherstenTSivertssonR.Peripheral arterial insufficiency. Effect of physical training on walking tolerance, calf blood flow, and blood flow resistance. Scand J Rehab Med1976; 8: 19–26.
29.
LarsenOALassenNA. Effect of daily muscular exercise in patients with intermittent claudication. Lancet1966; ii: 1093–96.
30.
HolmJDahllofABjomtorpPScherstenT.Enzyme studies in muscles of patients with intermittent claudication. Effect of training. Scand J Clin Lab Invest1973; 31 (suppl 128): 201–205.
31.
MannarinoEPasqualiniLInnocenteSScriccioloVRignaneseACiuffettiG.Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: Alone or combined?Angiologv, 1991; 42: 513–21.
32.
GardnerAWPoehlmanET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA1995; 274: 975–80.
33.
US Department of Health and Human Services.Physical activity and health: a report of the surgeon general.Atlanta, GA: US Department of Health and Human Services. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.
34.
RegensteinerJGMeyerTKrupskiWCranfordLSHiattWR. Comparison of home vs hospital based rehabilitation for patients with peripheral arterial disease. Angiology1997 (in press).
35.
JonasonTRingqvistIOman-RydbergA.Home-training of patients with intermittent claudication. Scand J Rehab Med1981; 13: 137–41.
36.
NeilsenSLLarsenBPrahlMJensenCTJensenBEWenkensV.Hospitalstraening contra hjemmetraening af patienter med claudicatio intermittens. Ugeskr for Laeger1977; 139: 2733–36.
37.
AlpertJSLarsenOALassenNA. Exercise and intermittent claudication. Blood flow in the calf muscle during walking studied by the xenon-133 clearance method. Circulation1969; 39: 353–59.
38.
ZetterquistS.The effect of active training on the nutritive blood flow in exercising ischemic legs. Scand J Clin Lab Invest1970; 25: 101–11.
39.
BlumchenGLandryFKieferHSchlosserV.Hemodynamic responses of claudicating extremities. Evaluation of a long range exercise program. Cardiology1970; 55: 114–27.
40.
ErnstEEWMatraiA.Intermittent claudication, exercise, and blood rheology. Circulation1987; 76: 1110–14.
41.
HiattWRRegensteinerJGCarryMWolfelEEBrassEP. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol1996; 81: 780–88.
42.
RegensteinerJGHiattWR. Benefits of exercise rehabilitation for patients with peripheral arterial disease. Exerc Sport Sci Rev1995; 23: 1–24.
